STRIANT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Striant, and when can generic versions of Striant launch?
Striant is a drug marketed by Auxilium Pharms Llc and is included in one NDA.
The generic ingredient in STRIANT is testosterone. There are sixty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Striant
A generic version of STRIANT was approved as testosterone by ACTAVIS LABS UT INC on January 27th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for STRIANT?
- What are the global sales for STRIANT?
- What is Average Wholesale Price for STRIANT?
Summary for STRIANT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Patent Applications: | 4,285 |
Drug Prices: | Drug price information for STRIANT |
What excipients (inactive ingredients) are in STRIANT? | STRIANT excipients list |
DailyMed Link: | STRIANT at DailyMed |
US Patents and Regulatory Information for STRIANT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Auxilium Pharms Llc | STRIANT | testosterone | TABLET, EXTENDED RELEASE;BUCCAL | 021543-001 | Jun 19, 2003 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for STRIANT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Auxilium Pharms Llc | STRIANT | testosterone | TABLET, EXTENDED RELEASE;BUCCAL | 021543-001 | Jun 19, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Auxilium Pharms Llc | STRIANT | testosterone | TABLET, EXTENDED RELEASE;BUCCAL | 021543-001 | Jun 19, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for STRIANT
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Warner Chilcott UK Ltd. | Intrinsa | testosterone | EMEA/H/C/000634 Intrinsa is indicated for the treatment of hypoactive sexual desire disorder (HSDD) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy. |
Withdrawn | no | no | no | 2006-07-28 | |
Warner ChilcottĀ Deutschland GmbH | Livensa | testosterone | EMEA/H/C/000630 Livensa is indicated for the treatment of hypoactive sexual desire disorder (HSDD) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy. |
Withdrawn | no | no | no | 2006-07-28 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for STRIANT
See the table below for patents covering STRIANT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 331255 | ⤷ Sign Up | |
Peru | 05192001 | ⤷ Sign Up | |
Malaysia | 125919 | BIOADHESIVE PROGRESSIVE HYDRATION TABLETS AND METHODS OF MAKING AND USING THE SAME | ⤷ Sign Up |
South Africa | 200104935 | Extended release buccal tablet. | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |